“…Levorphanol is a full agonist at both MOPr and DOPr, and a partial KOPr agonist (Le Rouzic et al, 2019). Levorphanol was effective in treating chronic pain resulting from malignancies and bone or joint disease (Glazebrook, 1952), and post-operative pain following abdominal surgery (Morrison et al, 1971). In addition, as a strong N-methyl-D-aspartate (NMDA) receptor antagonist (Pham et al, 2015), levorphanol has inhibitory effects on the uptake of This article has not been copyedited and formatted.…”